Saltar al contenido
Merck

A phospho-dependent mechanism involving NCoR and KMT2D controls a permissive chromatin state at Notch target genes.

Nucleic acids research (2016-02-26)
Franz Oswald, Patrick Rodriguez, Benedetto Daniele Giaimo, Zeus A Antonello, Laura Mira, Gerhard Mittler, Verena N Thiel, Kelly J Collins, Nassif Tabaja, Wiebke Cizelsky, Melanie Rothe, Susanne J Kühl, Michael Kühl, Francesca Ferrante, Kerstin Hein, Rhett A Kovall, Maria Dominguez, Tilman Borggrefe
RESUMEN

The transcriptional shift from repression to activation of target genes is crucial for the fidelity of Notch responses through incompletely understood mechanisms that likely involve chromatin-based control. To activate silenced genes, repressive chromatin marks are removed and active marks must be acquired. Histone H3 lysine-4 (H3K4) demethylases are key chromatin modifiers that establish the repressive chromatin state at Notch target genes. However, the counteracting histone methyltransferase required for the active chromatin state remained elusive. Here, we show that the RBP-J interacting factor SHARP is not only able to interact with the NCoR corepressor complex, but also with the H3K4 methyltransferase KMT2D coactivator complex. KMT2D and NCoR compete for the C-terminal SPOC-domain of SHARP. We reveal that the SPOC-domain exclusively binds to phosphorylated NCoR. The balance between NCoR and KMT2D binding is shifted upon mutating the phosphorylation sites of NCoR or upon inhibition of the NCoR kinase CK2β. Furthermore, we show that the homologs of SHARP and KMT2D in Drosophila also physically interact and control Notch-mediated functions in vivo Together, our findings reveal how signaling can fine-tune a committed chromatin state by phosphorylation of a pivotal chromatin-modifier.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Monoclonal ANTI-FLAG® M5 antibody produced in mouse, clone M5, purified immunoglobulin, buffered aqueous solution